3 assets in New-Onset Refractory Status Epilepticus

Therapeutic assets addressing New-Onset Refractory Status Epilepticus, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anakinra New-Onset Refractory Status Epilepticus	Yale University	P3	B (60)
Tocilizumab New-Onset Refractory Status Epilepticus	Yale University	P3	B (60)
Perampanel New-Onset Refractory Status Epilepticus	Wayne State University	P4	NR ()